![]() |
![]() |
Your cart is empty |
||
Showing 1 - 2 of 2 matches in All Departments
Up to 40 volumes are planned for this concise monograph series, which focuses on the implementation of various engineering principles in the conception, design, development, analysis and operation of biomedical, biotechnological and nanotechnology systems and applications. The smartness of nano-materials is attributed to their nanoscale and subsequently unique physicochemical properties and their use in glucose sensing has been aimed at improving performance, reducing cost and miniaturizing the sensor and its associated instrumentation. So far, portable (handheld) glucose analysers were introduced for hospital wards, emergency rooms and physicians' offices; single-use strip systems achieved nanolitre sampling for painless and accurate home glucose monitoring; advanced continuous monitoring devices having 2 to 7 days operating life are in clinical and home use; and continued research efforts are being made to develop and introduce increasingly advanced glucose monitoring systems for health as well as food, biotechnology, cell and tissue culture industries. Nanomaterials have touched every aspect of biosensor design and this chapter reviews their role in the development of advanced technologies for glucose sensing, and especially for diabetes. Research shows that overall, nanomaterials help address the problems with conventional optical and electrochemical biosensors, by enhancing the preferential detection of glucose or its oxidation products through better electron transfer kinetics, sensitivity and response time, while lowering the operating over-voltages for energy efficiency and avoid interference. The reproducible production of nano-materials and nano-structures at low cost is vital for the successful development of nano-technologies for glucose sensing. Several products, especially, home glucose monitoring devices, use nano-materials, but the need for reliable long-term CGM is still unmet. Nano-materials and nano-technologies have an important role in achieving the long-awaited CGM technology.
Over the past 20 years, the field of biosensor research has had a
significant impact in both laboratory research and the commercial
sector. Over that period, biosensors have revolutionized the care
and management of diabetes and have had important impacts in
several other areas of clinical diagnostics. Europe, North America
and Asia-Pacific have all seen the rise of small and medium sized
companies seeking technical and application niches in the
manufacture or use of biosensors. The current activity in both gene
and protein 'biochips' can be seen as the latest set of tools that
allow users who are not analytical science practitioners to make
technically complex and reliable biological weapons and the need
for their rapid and reliable detection will need to be met by
devices that have many characteristics in common with biosensors.
|
![]() ![]() You may like...
The Changing Global Economy and its…
Hamid Etemad, Stefano Denicolai, …
Hardcover
R3,874
Discovery Miles 38 740
Do. Fail. Learn. Repeat. - The Truth…
Nicholas Haralambous
Paperback
|